To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.
Find out MoreTIDM | HYG |
---|---|
Ticker Code | HYG.L |
ISIN | GB0031256109 |
Currency | GBX |
Issue Country | GB |
Sector | NMX302040 |
Year End | 31-Dec-23 |
Shares in Issue | 31.67m |
---|---|
Market Cap. | £4.28m |
Market Size | 1 |
PE Ratio | -0.813253 |
Earnings | -16.60 |
Dividend | 2.00 |
Yield | 14.815% |
# of Trades | 0 |
---|---|
Vol Sold | 0 |
Vol Bought | 0 |
52 Week High | 21.50 |
52 Week High Date | 19-Jun-2023 |
52 Week Low | 13.00 |
52 Week Low Date | 19-Oct-2023 |
Standard | GAAP | GAAP | GAAP | GAAP | GAAP |
---|---|---|---|---|---|
Millions | Millions | Millions | Millions | Millions | |
Income Statement | 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 |
Turnover | n/a | n/a | n/a | n/a | n/a |
Operating Profit / Loss | (0.31) | (0.27) | (0.02) | n/a | n/a |
Net Interest | n/a | n/a | n/a | n/a | n/a |
Pre Tax Profit | (0.31) | (0.27) | (0.02) | n/a | n/a |
Post Tax Profit | (0.31) | (0.27) | (0.02) | n/a | n/a |
Continuing EPS | |||||
Earnings per Share (Basic) | n/a | n/a | n/a | n/a | n/a |
Earnings per Share (Diluted) | n/a | n/a | n/a | n/a | n/a |
Earnings per Share (Adjusted) | n/a | n/a | n/a | n/a | n/a |
Continuing and Discontinued EPS | |||||
Earnings per Share (Basic) | (0.40p) | (0.30p) | (0.20p) | n/a | n/a |
Earnings per Share (Diluted) | (0.40p) | (0.30p) | (0.20p) | n/a | n/a |
Earnings per Share (Adjusted) | (0.40p) | (0.30p) | (0.20p) | n/a | n/a |
Dividend per Share | 2.00p | 2.00p | 4.00p | 13.00p | 18.00p |
Millions | Millions | Millions | Millions | Millions | |
Balance Sheet | 31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 |
Non-Current Assets | |||||
Intangible Assets | n/a | n/a | n/a | n/a | n/a |
Tangible Assets | n/a | n/a | n/a | n/a | n/a |
Fixed Investments | 11.86 | 13.58 | 3.21 | 2.14 | 2.07 |
Total Fixed Assets | 11.86 | 13.58 | 3.21 | 2.14 | 2.07 |
Current Assets | |||||
Stocks | n/a | n/a | n/a | n/a | n/a |
Debtors | 0.01 | 0.01 | n/a | n/a | n/a |
Cash at Bank and in Hand | 1.46 | 5.07 | 0.32 | 0.53 | 0.47 |
Total Assets | 17.23 | 18.65 | 3.53 | 2.67 | 2.54 |
Current Liabilities | |||||
Creditors Within 1Yr | 0.19 | 0.17 | 0.02 | 0.02 | 0.02 |
Net Current Assets | 5.17 | 4.91 | 0.30 | 0.51 | 0.45 |
Non-Current Liabilities | |||||
Creditors After 1Yr | 0.15 | 0.35 | 0.35 | 0.19 | 0.05 |
Net Assets | 16.89 | 18.13 | 3.16 | 2.45 | 2.46 |
Capital and Reserves | |||||
Called Up Share Capital | 0.30 | 0.27 | 0.08 | 0.08 | 0.08 |
Share Premium Account | 1.08 | 14.54 | n/a | n/a | n/a |
Other Reserves | 18.57 | 6.07 | 5.04 | 4.32 | 4.33 |
Shareholders Funds | 16.89 | 18.13 | 3.16 | 2.45 | 2.46 |
Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
31 Dec '23 | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | |
Operating Margin | (10,200.00%) | n/a | n/a | n/a | n/a |
Return on Capital Employed | n/a | n/a | n/a | n/a | n/a |
Dividend Cover | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | 33.30 | n/a |
PE Ratio | n/a | n/a | n/a | n/a | n/a |
PEG | n/a | n/a | n/a | n/a | n/a |
Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
Net Asset Value per Share | 208.15p | 223.40p | 38.90p | 30.23p | 30.35p |